Amanda E. Clarke
机构：Brighton and Sussex Medical School, Royal Sussex County Hospital
发表论文 4 篇 · 总被引 878 次 · h-index 4
代表论文
- Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials (2018 · The Lancet · 被引 385)
- Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials (2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 214)
- Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate (2019 · AIDS · 被引 162)
- Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results (2017 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 117)